Vivos (RDGL) Cash from Operations Growth (5y) (2015 - 2025)
Vivos (RDGL) Cash from Operations Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.10% |
| Sep 30, 2025 | -20.04% |
| Jun 30, 2025 | -20.39% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -22.31% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | -5.28% |
| Dec 31, 2023 | 2.76% |
| Sep 30, 2023 | -25.62% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -43.47% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | 19.34% |
| Mar 31, 2022 | -6.87% |
| Dec 31, 2021 | 41.95% |
| Sep 30, 2021 | -15.52% |
| Jun 30, 2021 | 17.58% |
| Mar 31, 2021 | 18.73% |